Trademark: 85318930
Word
ADVANCING SCIENCE. ENHANCING VISION.
Status
Registered
Status Code
701
Status Date
Thursday, April 21, 2022
Serial Number
85318930
Registration Number
4834268
Registration Date
Tuesday, October 20, 2015
Mark Type
4000
Filing Date
Thursday, May 12, 2011
Published for Opposition
Tuesday, August 4, 2015

Trademark Owner History
OXURION -
ThromboGenics NV - Original Registrant

Classifications
42 Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, [ cardiac, ] inflammation, [ hypertension, immune system, blood and cancer ] disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial research analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
Color is not claimed as a feature of the mark.

Trademark Events
Dec 23, 2022
Teas Change Of Correspondence Received
Dec 23, 2022
Teas Change Of Domestic Representatives Address
Dec 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 21, 2022
Notice Of Acceptance Of Sec. 8 - E-Mailed
Apr 21, 2022
Registered - Sec. 8 (6-Yr) Accepted
Apr 14, 2022
Case Assigned To Post Registration Paralegal
Oct 27, 2021
Automatic Update Of Assignment Of Ownership
Oct 20, 2021
Teas Section 8 Received
Oct 20, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 20, 2015
Registered-Principal Register
Aug 4, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2015
Published For Opposition
Jul 15, 2015
Notification Of Notice Of Publication E-Mailed
Jun 30, 2015
Electronic Record Review Complete
Jun 26, 2015
On Hold - Electronic Record Review Required
Jun 24, 2015
Electronic Record Review Complete
May 29, 2015
On Hold - Electronic Record Review Required
May 26, 2015
Notice Of Allowance Cancelled
May 20, 2015
Petition To Director - Change Basis - Granted
May 14, 2015
Assigned To Petition Staff
May 7, 2015
Notice Of Approval Of Extension Request E-Mailed
May 5, 2015
Sou Extension 5 Granted
May 5, 2015
Sou Extension 5 Filed
May 5, 2015
Teas Extension Received
Apr 29, 2015
Teas Petition To Amend Basis Received
Dec 5, 2014
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2014
Sou Extension 4 Granted
Oct 31, 2014
Sou Extension 4 Filed
Dec 3, 2014
Case Assigned To Intent To Use Paralegal
Oct 31, 2014
Teas Change Of Correspondence Received
Oct 31, 2014
Teas Extension Received
May 7, 2014
Notice Of Approval Of Extension Request E-Mailed
May 5, 2014
Sou Extension 3 Granted
May 5, 2014
Sou Extension 3 Filed
May 5, 2014
Teas Extension Received
Nov 6, 2013
Notice Of Approval Of Extension Request E-Mailed
Nov 4, 2013
Sou Extension 2 Granted
Nov 4, 2013
Sou Extension 2 Filed
Nov 4, 2013
Teas Extension Received
May 4, 2013
Notice Of Approval Of Extension Request E-Mailed
May 2, 2013
Sou Extension 1 Granted
May 2, 2013
Sou Extension 1 Filed
May 2, 2013
Teas Extension Received
Nov 6, 2012
Noa E-Mailed - Sou Required From Applicant
Sep 11, 2012
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2012
Published For Opposition
Aug 22, 2012
Notification Of Notice Of Publication E-Mailed
Aug 3, 2012
Law Office Publication Review Completed
Jul 31, 2012
Assigned To Lie
Jul 17, 2012
Approved For Pub - Principal Register
Jul 6, 2012
Teas/Email Correspondence Entered
Jul 6, 2012
Correspondence Received In Law Office
Jul 6, 2012
Teas Request For Reconsideration Received
Jan 25, 2012
Notification Of Final Refusal Emailed
Jan 25, 2012
Final Refusal E-Mailed
Jan 25, 2012
Final Refusal Written
Jan 4, 2012
Teas/Email Correspondence Entered
Jan 4, 2012
Correspondence Received In Law Office
Jan 4, 2012
Teas Response To Office Action Received
Dec 8, 2011
Assigned To Examiner
Sep 3, 2011
Notification Of Non-Final Action E-Mailed
Sep 3, 2011
Non-Final Action E-Mailed
Sep 3, 2011
Non-Final Action Written
Aug 29, 2011
Assigned To Examiner
May 17, 2011
New Application Office Supplied Data Entered In Tram
May 16, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24